The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 2 rounds in the feed, most often in Biotech.
Aisling Capital is a leading investment firm that invests in companies developing and commercializing important and innovative healthcare products, services and technologies.
Venture capitalNew York, NY, USAaislingcapital.comRounds from 2022-06-14 to 2026-10-28
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Dren Bio A privately held, clinical-stage biotechnology company developing first-in-class antibody therapeutics for cancer, autoimmune, and other serious diseases | Funding round Verified against 2 of 3 sources | $350M | 2026-10-28 | [ PART ] |
Dren Bio A privately held, clinical-stage biotechnology company developing first-in-class antibody therapeutics for cancer, autoimmune, and other serious diseases | Series B |
| $65M |
| 2022-06-14 |
| [ LEAD ] |